Home / Americas / Mexico / Life Sciences & Healthcare
earth viewed from the space shuttle

Life Sciences & Healthcare

Mexico’s Life Sciences & Healthcare accounts for 12% of gross domestic product. Companies operating in the sector face significant challenges, with a complex regulatory landscape, strong influence from the government both as a regulator and as the biggest buyer, and intense competition from local and international stakeholders.

CMS Woodhouse Lorente Ludlow lawyers understand the complexity of an interdisciplinary business, have deep understanding of the law and are very aware of the scientific and commercial aspects related to your business. This gives us the ability to design and implement regulatory and government affairs strategies to achieve clients’ business goals.

The team has experience advising clients through the entire productive process of regulated products, manufacturing, warehousing, transportation, distribution, imports and exports, retail and advertisements. We are experts in advising companies with new businesses and products, drafting regulatory strategies, performing regulatory compliance audits, advising on good manufacturing practices and certifications, premarket approval of products and services, health licences, cross-border classification of products, and advice on approval of labelling and marketing of regulated products and services.

We also represent clients before the health authorities in regulatory enforcement administrative procedures and design crisis management strategies in cases of voluntary recall of products, seizure of products by the authorities and closure of facilities.


Feed

15/09/2022
Phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising in...
1. Which laws are ap­plic­able re­gard­ing ad­vert­ising of medi­cines and med­ic­al devices? The primary le­gis­la­tion for medi­cines and med­ic­al devices ad­vert­ise­ment is The Gen­er­al Health Law (Ley Gen­er­al de...
08/09/2022
Can­nabis law and le­gis­la­tion in Mex­ico
Med­ic­al use Med­ic­al use is al­lowed. In Janu­ary 2021 the Rules of Med­ic­al Can­nabis were is­sued by the Min­istry of Health. While CBD is not ad­dressed in the Gen­er­al Health Law, it is defined in the Rules...
07/06/2022
Trade secret laws and reg­u­la­tions in Mex­ico
Gen­er­al 1. Has the Dir­ect­ive (EU) 2016/943 of the European Par­lia­ment and of the Coun­cil of 8 June 2016 on the pro­tec­tion of un­dis­closed know-how and busi­ness in­form­a­tion (trade secrets) against their...
Comparable
07/06/2022
Ad­verse ef­fects of drugs and vac­cines in Mex­ico
1. Drug ad­verse ef­fects: kinds of re­spons­ib­il­ity 1.1 Which are the main kinds of re­spons­ib­il­ity (con­trac­tu­al, in tort, crim­in­al) of the fol­low­ing sub­jects with re­spect to ad­verse drugs re­ac­tions? Un­der...
Comparable
01/06/2022
CMS Next
What’s next? In a world of ever-ac­cel­er­at­ing change, stay­ing ahead of the curve and know­ing what’s next for your busi­ness or sec­tor is es­sen­tial.At CMS, we see ourselves not only as your leg­al ad­visers but also as your busi­ness part­ners. We work to­geth­er with you to not only re­solve cur­rent is­sues but to an­ti­cip­ate fu­ture chal­lenges and in­nov­ate to meet them.With our latest pub­lic­a­tion, CMS Next, our ex­perts will reg­u­larly of­fer you in­sights in­to and fresh per­spect­ives on a range of is­sues that busi­nesses have to deal with – from ESG agen­das to re­struc­tur­ing after the pan­dem­ic or fa­cing the di­git­al trans­form­a­tion. We will also share with you more about the work that we are do­ing for our cli­ents, help­ing them in­nov­ate, grow and mit­ig­ate risk.To be able to provide you with the best sup­port, we im­merse ourselves in your world to un­der­stand your leg­al needs and chal­lenges. However, it is equally im­port­ant that you know who we are and how we can work with you. So, we in­vite you to meet our ex­perts and catch a glimpse of what is hap­pen­ing in­side CMS.En­joy read­ing this pub­lic­a­tion, which we will up­date reg­u­larly with new con­tent.CMS Ex­ec­ut­ive Team
04/04/2022
Más allá de la marca per­son­al
El se­gundo re­porte de CMS Lat­inoamérica, "Guía para ger­entes le­gales: Más allá de la marca per­son­al”, in­vest­iga sobre la im­port­an­cia de la marca per­son­al (MP) como her­rami­enta para po­ten­ciar la...
26/11/2021
COV­ID-19 vac­cin­a­tion and test­ing in Mex­ico - em­ploy­ment law per­spect­ive
Vac­cin­a­tion 1. What op­tions does the em­ploy­er have to en­cour­age em­ploy­ees to be vac­cin­ated? Can the em­ploy­er provide a fin­an­cial in­cent­ive to em­ploy­ees?  There are no op­tions for the em­ploy­er to en­cour­age...
Comparable
24/11/2021
On the Pulse
Wel­come to CMS ‘On the Pulse’ video/pod­cast series for all Life Sci­ences & Health­care pro­fes­sion­als – leg­al, com­pli­ance, reg­u­lat­ory
14/12/2020
Di­git­al health apps and telemedi­cine in Mex­ico
Di­git­al Health Apps/Soft­ware 1. How is the soft­ware with­in di­git­al health apps clas­si­fied in your jur­is­dic­tion, and what reg­u­la­tion(s) ap­ply? Soft­ware with­in Di­git­al Health Apps and telemedi­cine are...
Comparable
11/05/2020
AI in Life Sci­ences
Ar­ti­fi­cial in­tel­li­gence is not new: the term it­self was coined over 60 years ago. However, the con­ver­gence of data volume, pro­cessing power and tech­nic­al cap­ab­il­ity has con­vinced many that the AI era...
20/08/2019
First Su­preme Court Rul­ing for Med­ic­al Use of Can­nabis in Mex­ico
Mex­ico CityBy un­an­im­ous vote, the Min­is­ters of the Second Cham­ber of Mex­ico’s Su­preme Court of Justice de­cided to grant the pro­tec­tion of Fed­er­al Justice to a minor child with a dia­gnos­is of epi­lepsy...